|
Doksum, Teresa; Bernhardt, Barbara A; Holtzman, Neil A (2003) Does knowledge about the genetics of breast cancer differ between nongeneticist physicians who do or do not discuss or order BRCA testing? Genet Med 5:99-105
|
|
Doksum, T; Bernhardt, B A; Holtzman, N A (2001) Carrier screening for cystic fibrosis among Maryland obstetricians before and after the 1997 NIH Consensus Conference. Genet Test 5:111-6
|
|
Schoonmaker, M M; Bernhardt, B A; Holtzman, N A (2000) Factors influencing health insurers' decisions to cover new genetic technologies. Int J Technol Assess Health Care 16:178-89
|
|
Holtzman, N A (1998) Eugenics and genetic testing. Sci Context 11:397-417
|
|
Geller, G; Strauss, M; Bernhardt, B A et al. (1997) ""Decoding"" informed consent. Insights from women regarding breast cancer susceptibility testing. Hastings Cent Rep 27:28-33
|
|
Holtzman, N A (1996) Medical and ethical issues in genetic screening--an academic view. Environ Health Perspect 104 Suppl 5:987-90
|
|
Holtzman, N A (1994) Benefits and risks of emerging genetic technologies: the need for regulation. Clin Chem 40:1652-7
|
|
Holtzman, N A (1993) Primary care physicians as providers of frontline genetic services. Fetal Diagn Ther 8 Suppl 1:213-9
|
|
Geller, G; Tambor, E S; Chase, G A et al. (1993) Measuring physicians' tolerance for ambiguity and its relationship to their reported practices regarding genetic testing. Med Care 31:989-1001
|
|
Geller, G; Tambor, E S; Bernhardt, B A et al. (1993) Physicians' attitudes toward disclosure of genetic information to third parties. J Law Med Ethics 21:238-40
|
Showing the most recent 10 out of 14 publications
